Joseph Pultar

Sankt Poelten, 3100, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Sex-Related Differences in On-Treatment Platelet Reactivity in Patients with Acute Coronary Syndrome.

Sex-Related Differences in On-Treatment Platelet Reactivity in Patients with Acute Coronary Syndrome.

Journal: Biomedicines

Published: August 04, 2025

Glycocalyx Disintegration Is Associated with Mortality in Chronic Heart Failure.

Glycocalyx Disintegration Is Associated with Mortality in Chronic Heart Failure.

Journal: Journal of clinical medicine

Published: April 02, 2025

Elderly patients are hyperresponsive to potent P2Y12 inhibitors.

Elderly patients are hyperresponsive to potent P2Y12 inhibitors.

Journal: Research and practice in thrombosis and haemostasis

Published: October 06, 2024

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome.

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome.

Journal: Journal of clinical medicine

Published: December 30, 2022

Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y12 Inhibitors.

Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y12 Inhibitors.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: April 28, 2022

Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization.

Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization.

Journal: Atherosclerosis

Published: June 20, 2021

Microvascular rarefaction in patients with cerebrovascular events.

Microvascular rarefaction in patients with cerebrovascular events.

Journal: Microvascular research

Published: February 07, 2021

Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome.

Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome.

Journal: Thrombosis and haemostasis

Published: January 20, 2021

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?

Journal: Cardiovascular drugs and therapy

Published: December 10, 2020

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors.

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: October 27, 2020

Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia.

Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia.

Journal: Cardiovascular drugs and therapy

Published: August 17, 2020

Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes.

Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes.

Journal: Cardiovascular drugs and therapy

Published: February 17, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026